Streamlining Genetic Test Ordering and Resulting Through the Electronic Health Record with Katherine L. Nathanson, MD, Stephanie Asher, MS, CGC, and Jordan Trivison

In this webinar, we will discuss the intricacies of effectively integrating genomic test ordering and results into an EHR system and discuss the importance of standardizing the process. We will highlight a real world integration of genomic data, which has been recently described in detail in a publication in Genetics in Medicine: Lau-Min KS et al. Real-world integration of genomic data into the electronic health record: the PennChart Genomics Initiative. Genet Med. 2021 Apr;23(4):603-605. doi: 10.1038/s41436-020-01056-y. Epub 2020 Dec 10.

Level of Instruction: Intermediate

Katherine L. Nathanson, MD | Presenter

Pearl Basser Professor of BRCA-related Research
Deputy Director, Abramson Cancer Center
University of Pennsylvania

Katherine (Kate) L. Nathanson, MD is a Professor of Medicine, in the Division of Translational Medicine and Human Genetics, and Genetics, at the Perelman School of Medicine of the University of Pennsylvania. She is Deputy Director of the Abramson Cancer Center, and Director of Genetics for the Basser Center for BRCA. Dr. Nathanson received her BA from Haverford College and MD from the University of Pennsylvania School of Medicine. She completed residencies in both Internal Medicine and Clinical Genetics, along with a post-doctoral fellowship in cancer genetics. She is an internationally recognized for both her clinical and research expertise in cancer genetics/genomics. Her research focuses on both inherited susceptibility to cancer and somatic genetic characterization of tumors, with interests across multiple tumor types, including testicular germ cell tumors, hereditary breast and ovarian cancers, melanoma and neuroendocrine tumors. Dr. Nathanson has published over 270 peer-reviewed articles in journals such as Nature, JAMA, New England Journal of Medicine and Cancer Cell. Dr. Nathanson has an extensive record of national service, serving on committees for multiple organizations, such as ACMG and AACR, several editorial boards, and scientific review committees including as Chair of the Cancer Genetics study section for the National Institutes of Health. She has been elected to the American Society of Clinical Investigation and the American Association of Physicians, and recently received the Osler Award for Patient Oriented Research at the University of Pennsylvania School of Medicine.

Stephanie Asher, MS, CGC | Presenter

Associate Director of Genetic Counseling, Division of Translational Medicine and Human Genetics, University of Pennsylvania

Stephanie Asher, MS CGC, is a certified genetic counselor currently working at the University of Pennsylvania. Stephanie attended the College of William and Mary and then the University of Cincinnati Genetic Counseling Program. Stephanie has worked primarily as a clinical genetic counselor in the realm of rare cancer syndromes, connective tissue disorders, metabolic disorders and general genetics. In the past few years, Stephanie has been involved with the Penn Genomics Initiative, working to integrate genetic information more efficiently and effectively into the electronic medical record system for use in patient care.

Jordan Trivison | Presenter

Manager, Business Systems Analysis, Ambry Genetics

Jordan Trivison is a technology professional currently working at Ambry Genetics, a Konica Minolta Precision Medicine company, as Manager of Business Systems Analysis. Jordan has spent the past 10 years working in technology and in the development of software solutions for a variety of industries including, healthcare, laboratory, and real estate. Recently, Jordan’s focuses have been on developing a pipeline for data transfer integration between Ambry’s software and EHR systems.

Jill S. Dolinsky, MS, CGC | Moderator

Director, Clinical Affairs, Ambry Genetics

Jill S. Dolinsky, MS, CGC is the Director of Clinical Affairs at Ambry Genetics. In this role, she drives efforts to enhance patient access to genetic testing by demonstrating the clinical utility of molecular genetic testing through data sharing, peer-review publication, and engagement with professional societies. Her current research interests include the clinical utility of multigene panel testing for hereditary cancer and cardiovascular diseases, the importance of broad data sharing in the interpretation of genomic data, increasing patient access to genetic counseling and testing through innovative service delivery models and the assessment of rare variants. Prior to joining Ambry in 2011, she worked in cardiovascular genetics at the University of Miami Miller School of Medicine, researching genetic etiologies of familial dilated cardiomyopathy along with practicing clinical cardiovascular genetics. In addition, she spent four years practicing cancer genetic counseling in the University of Pennsylvania Health System. She has more than 50 peer-reviewed publications in molecular genetics and has been an invited lecturer at numerous scientific meetings.